Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, today announced the appointment of Brian Roberts as President and Chief Executive Officer effective September 30, 2020.
September 30, 2020
· 4 min read